Since our founding, Tulane has been on the front lines of both infectious disease research and defense against outbreaks – it is the foundation upon which the university was built.
100&Change
Tulane can look at a problem from “bench to bedside,” beginning with the molecular biology level, rising through animal models and ultimately to clinical trials among our large patient population. And Tulane’s relatively small size among Research 1 institutions is an asset, providing the agility and closely interconnected type of community that can respond to changes and new information quickly — both major characteristics of this pandemic. Learn more about the unique way we look at infectious disease in our MacArthur 100&Change submission.
Powerful Research,
Powerful Response
At Tulane, world-class investigators are working in a highly collaborative fashion to answer questions that have not been asked in the last century. Matched with a unique sense of purpose is a unique set of resources that positions Tulane ahead of other institutions. Join us in being part of a new tomorrow.